Serum Insulin-Like Growth Factor-1 in Patients with De Novo, Drug Naïve Parkinson’s Disease: A Meta-Analysis

OBJECTIVE: Insulin-like growth factor-1 (IGF-1) is reported to be neuroprotective in the setting of Parkinson’s disease (PD), and there is increasing interest in the possible association of serum IGF-1 levels with PD patients, but with conflicting results. Therefore, we conducted a meta-analysis to...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Dun-Hui, He, Ya-Chao, Quinn, Thomas J., Liu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684362/
https://www.ncbi.nlm.nih.gov/pubmed/26657015
http://dx.doi.org/10.1371/journal.pone.0144755

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684362/
https://www.ncbi.nlm.nih.gov/pubmed/26657015
http://dx.doi.org/10.1371/journal.pone.0144755

Ejemplares similares